LOC439994 Inhibitors
The classification of LOC439994 Inhibitors pertains to a specific group of chemical compounds engineered to modulate the activity of LOC439994, a molecular entity whose functional roles and biological significance are currently under investigation within the scientific community. These inhibitors are meticulously designed based on principles found in medicinal chemistry, emphasizing their capacity to selectively interfere with the normal functions of LOC439994 within cellular processes. The structural composition of LOC439994 Inhibitors undergoes a rigorous optimization process, involving computational modeling and structure-activity relationship studies, aimed at refining their molecular configurations to ensure effective binding to the target.
LOC439994 Inhibitors are characterized by their ability to disrupt the biochemical activities associated with LOC439994, which is presumed to play a pivotal role in various biological pathways. The ongoing research in this field seeks to unravel the three-dimensional structure of LOC439994 and its binding interactions with inhibitors, facilitating a deeper understanding of the molecular mechanisms underlying inhibition. The study of LOC439994 Inhibitors contributes to a broader comprehension of cellular processes and the intricate interplay of molecular components within biological systems. This research aids in expanding the scientific knowledge surrounding LOC439994, shedding light on its involvement in diverse biological functions and furthering our understanding of the complex regulatory networks governing cellular activities.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Siomycin A | 12656-09-6 | sc-202339 sc-202339-CW sc-202339A sc-202339B | 500 µg 500 µg 2.5 mg 25 mg | $450.00 $500.00 $1350.00 $10404.00 | 4 | |
Siomycin A is a thiazole antibiotic that can inhibit the transcription factor FoxM1, which may be involved in the transcription of certain lncRNAs. Inhibiting this transcription factor could hypothetically reduce the expression of LINC00863 if it is regulated by FoxM1. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108 is a DNA methyltransferase inhibitor that might prevent the methylation of CpG islands near the promoter regions of lncRNAs like LINC00863, potentially suppressing its expression by maintaining a silenced state of the associated gene. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin is known to have a wide range of biological effects, including the modulation of various signaling pathways and potentially influencing gene expression, which could hypothetically alter the expression of LINC00863. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram can chelate copper to form a complex that inhibits the proteasome. This indirect effect on protein degradation might affect the stability of proteins involved in the transcription or stabilization of LINC00863, potentially leading to its decreased expression. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
C646 is a selective inhibitor of histone acetyltransferase p300, which could hypothetically reduce the acetylation of histones, leading to a more condensed chromatin state and potentially downregulating the expression of LINC00863. | ||||||
Plumbagin | 481-42-5 | sc-253283 sc-253283A | 100 mg 250 mg | $52.00 $62.00 | 6 | |
Plumbagin is known to alter various signaling pathways and could potentially modify the expression of LINC00863 through changes in the cellular milieu that affect gene expression regulation. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide is a diterpene triepoxide that has been shown to inhibit the transcription of certain genes. Its broad effects on gene expression might extend to lncRNAs like LINC00863, potentially decreasing its expression. | ||||||
Homocysteine | 6027-13-0 | sc-507315 | 250 mg | $195.00 | ||
As a product inhibitor of S-adenosyl-L-methionine-dependent methyltransferases, S-Adenosyl-L-homocysteine can affect the methylation status of genes and potentially influence the expression of LINC00863. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 inhibits the BET family of bromodomain proteins, which recognize acetylated lysine residues on histone tails. By inhibiting these proteins, JQ1 can suppress the expression of certain genes and could hypothetically affect the expression of LINC00863 as well. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Mocetinostat is a histone deacetylase inhibitor that could increase acetylation levels leading to an open chromatin state and potentially altered expression of lncRNAs such as LINC00863. | ||||||